Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23324573)

1.

Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study.

López-Gigosos R, Campins M, Calvo MJ, Pérez-Hoyos S, Díez-Domingo J, Salleras L, Azuara MT, Martínez X, Bayas JM, Ramón Torrell JM, Pérez-Cobaleda MA, Núñez-Torrón ME, Gorgojo L, García-Rodríguez M, Díez-Díaz R, Armadans L, Sánchez-Fernández C, Mejías T, Masuet C, Pinilla R, Antón N, Segarra P.

Hum Vaccin Immunother. 2013 Mar;9(3):692-8. Epub 2013 Jan 16.

2.

Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).

Gabutti G, Aquilina M, Cova M, Giuffrida S, Lizioli A, Protano D, Scrivano F, Tomasi A, Cucchi A, Cavallaro A; Collaborative Group for the Study of Fecal-Orally Transmitted Diseases in Travelers.

J Prev Med Hyg. 2012 Dec;53(4):199-203.

PMID:
23469588
3.

Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers.

Torrell JM, Aumatell CM, Ramos SM, Mestre LG, Salas CM.

Vaccine. 2009 Jun 19;27(30):4074-7. doi: 10.1016/j.vaccine.2009.04.025. Epub 2009 May 3.

PMID:
19376179
4.

Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.

López-Gigosos R, García-Fortea P, Reina-Doña E, Plaza-Martín E.

Travel Med Infect Dis. 2007 Nov;5(6):380-4. Epub 2007 Jul 30.

PMID:
17983977
5.

Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea.

López-Gigosos R, Garcia-Fortea P, Calvo MJ, Reina E, Diez-Diaz R, Plaza E.

BMC Infect Dis. 2009 May 16;9:65. doi: 10.1186/1471-2334-9-65.

6.

Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.

Lundkvist J, Steffen R, Jönsson B.

J Travel Med. 2009 Jan-Feb;16(1):28-34. doi: 10.1111/j.1708-8305.2008.00270.x. Erratum in: J Travel Med. 2009 Mar-Apr;16(2):147.

PMID:
19192125
7.

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.

Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F.

Cochrane Database Syst Rev. 2013 Jul 5;7:CD009029. doi: 10.1002/14651858.CD009029.pub2. Review.

PMID:
23828581
8.

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG.

Vaccine. 2005 Oct 17;23(43):5120-6.

PMID:
15982790
9.

Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.

Jelinek T, Kollaritsch H.

Expert Rev Vaccines. 2008 Jul;7(5):561-7. doi: 10.1586/14760584.7.5.561. Review.

PMID:
18564011
10.

[Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea].

Kollaritsch H, Wiedermann U.

Wien Med Wochenschr. 2007;157(5-6):102-6. Review. German.

PMID:
17427005
11.

Cholera vaccines.

Ryan ET, Calderwood SB.

Clin Infect Dis. 2000 Aug;31(2):561-5. Epub 2000 Sep 7. Review.

12.

Effectiveness of mass oral cholera vaccination in Beira, Mozambique.

Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Macuamule A, Cavailler P, Guerin PJ, Mahoudeau C, Kahozi-Sangwa P, Chaignat CL, Barreto A, Songane FF, Clemens JD.

N Engl J Med. 2005 Feb 24;352(8):757-67.

13.

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.

Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J.

Lancet Infect Dis. 2012 Nov;12(11):837-44. doi: 10.1016/S1473-3099(12)70196-2. Epub 2012 Sep 4.

PMID:
22954655
14.

Oral cholera vaccine--for whom, when, and why?

Topps MH.

Travel Med Infect Dis. 2006 Jan;4(1):38-42. Review.

PMID:
16887724
15.

Oral cholera vaccine for traveler's diarrhea prophylaxis.

Nickonchuk T, Lindblad AJ, Kolber MR.

Can Fam Physician. 2014 May;60(5):451.

16.

Vaccines against traveler's diarrhoea and rotavirus disease - a review.

Wiedermann U, Kollaritsch H.

Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):2-8. Review.

PMID:
17131234
17.

Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' Diarrhea.

Scerpella EG, Sanchez JL, Mathewson III JJ, Torres-Cordero JV, Sadoff JC, Svennerholm AM, DuPont HL, Taylor DN, Ericsson CD.

J Travel Med. 1995 Mar 1;2(1):22-27.

PMID:
9815355
18.

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.

Clemens JD, Sack DA, Harris JR, Chakraborty J, Neogy PK, Stanton B, Huda N, Khan MU, Kay BA, Khan MR, et al.

J Infect Dis. 1988 Aug;158(2):372-7.

PMID:
3042876
19.

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.

Hashim R, Khatib AM, Enwere G, Park JK, Reyburn R, Ali M, Chang NY, Kim DR, Ley B, Thriemer K, Lopez AL, Clemens JD, Deen JL, Shin S, Schaetti C, Hutubessy R, Aguado MT, Kieny MP, Sack D, Obaro S, Shaame AJ, Ali SM, Saleh AA, von Seidlein L, Jiddawi MS.

PLoS Negl Trop Dis. 2012;6(7):e1743. doi: 10.1371/journal.pntd.0001743. Epub 2012 Jul 24.

20.

Oral cholera vaccines: use in clinical practice.

Hill DR, Ford L, Lalloo DG.

Lancet Infect Dis. 2006 Jun;6(6):361-73. Review.

PMID:
16728322
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk